Dermatol. praxi. 2014;8(1):20-22

Perifolliculitis abscedens et suffodiens in patient succesfully treated with izotretinoid

MUDr.Helena Korandová, CSc.
Kožní ordinace Olomouc

Perifolliculitis abscedens et suffodiens is a rare chronic dermatosis of unknown origin that affects hairy scalp and neck. It is a part of acne

tetras and is present mostly in men over 20 years of age. Histopathology is necessary to asses the diagnosis. Peroral izotretinoin is the first

choice of the treatment. Other therapeutic modalities include surgery, antibiotics, dapsone and biological therapy (anti- TNFα). A case

of man treated succesfully with izotretinoin is described.

Keywords: perifolliculitis abscedens et suffodiens, histopathology, izotretinoin

Published: June 15, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Korandová H. Perifolliculitis abscedens et suffodiens in patient succesfully treated with izotretinoid. Dermatol. praxi. 2014;8(1):20-22.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Plewig G, Kligman AM. Acne and Rosacea. Third completely Revised and Enlarged Edition. Springer Verlag, 2000: 309. Go to original source...
    2. Lugovič-Mihič L, et al. Differential diagnosis of the scalp hair folliculitis. Acta Clin.Croat. 2011; 50(3): 395-402. Go to PubMed...
    3. Camacho F, Montagna W. Trichology. Aula Medica Group SA, 1997: 545-546.
    4. Branisteanu DE, et al. The importance of histopathologic aspects in the diagnosis of dissecting cellulitis of the scalp. Rom. J. Morphol. Embryol 2009; 50(4): 719-724.
    5. Georghala S, et al. Dissecting folliculitis of the scalp treated with rifampicin and Isotretinoin: case report. Cutis 2008; 82(3): 195-198. Go to PubMed...
    6. Bolz S, et al. Successful treatment of perifolliculitis capitis abscedens et suffodiens with combined isotretinoine and dapsone. J. Dtsch. Dermatol. Ges. 2008; 6(1): 44-47. Go to original source... Go to PubMed...
    7. Brandth HR, et al. Perifolliculitis capitis abscedens et suffodiens successfully controlled with infliximab. Br. J. Dermatol. 2008; 159(2): 506-507. Go to original source... Go to PubMed...
    8. Dubost-Brama A, et al. Perifolliculitis capitis abscedens et suffodiens. Efficacy of isotretinoin. Ann. Dermatol. Venereol. 1994; 121(4): 328-330. Go to PubMed...
    9. Curry SS, et al. Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. A case report and review of secondary squamous cell carcinomas. J. Am. Dermatol. 1981; 4(6): 673-678. Go to original source... Go to PubMed...
    10. Nevoralová Z. Izotretinoin v praxi. Mladá fronta, 2012: 119-120.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.